First gene therapy and plant-based expression vector products approved in 2012

2012 was a successful year in terms of product approvals. Twelve biopharmaceutical marketing applications were approved in the United States and/or the European Union in 2012. Approval numbers for the past year are in line with those recorded over the previous five years (1-4), which reveal a statistical average of 12.2 approvals annually.
Read More

Overview of a scale-up of a cell-based influenza virus production process using ReadyToProcess equipment

GE Healthcare Life Sciences single-use products can be successfully applied in the field of vaccine manufacturing, as demonstrated in this white paper. The paper includes a brief discussion around modern vaccine processes, followed by a case study showing the scale-up of upstream and downstream processes for the production of a cell based live attenuated influenza virus using single-use ReadyToProcess technology.
Read More